doc_id	sent_index	relation_id	relation	trigger	trigger_offset	arg_num	arg_base_np	arg_protein	arg_domain	arg_site	arg_sugar	PSource	SiteSource	NProtein	NID	SiteName	sent_text
24790018	1	10	gly	used	233:236	arg2	Murine lumbar and coccygeal (tail) regions			Murine lumbar and coccygeal (tail) regions						regions	Murine lumbar and coccygeal (tail) regions of spines are commonly used to study cellular signaling of age-related disc diseases, but the tissue-level changes of aging intervertebral discs and vertebrae of each spinal region remain unclear.
28757018	6	11	gly	glycoprotein	1242:1253	arg1	O-linked glycoprotein	O-linked glycoprotein				Fterm		glycoprotein			The infectivity of four NA-sensitive strains was equally reduced by inhibitors of lipid membrane and N-linked glycoprotein but not by an inhibitor of O-linked glycoprotein, indicating that these strains utilize both glycolipid and N-linked glycoprotein.
28757018	6	21	gly	glycoprotein	1193:1204	arg1	N-linked glycoprotein	N-linked glycoprotein				Fterm		glycoprotein			The infectivity of four NA-sensitive strains was equally reduced by inhibitors of lipid membrane and N-linked glycoprotein but not by an inhibitor of O-linked glycoprotein, indicating that these strains utilize both glycolipid and N-linked glycoprotein.
28757018	6	87	gly	glycoprotein	1323:1334	arg1	N-linked glycoprotein	N-linked glycoprotein				Fterm		glycoprotein			The infectivity of four NA-sensitive strains was equally reduced by inhibitors of lipid membrane and N-linked glycoprotein but not by an inhibitor of O-linked glycoprotein, indicating that these strains utilize both glycolipid and N-linked glycoprotein.
26793973	11	86	gly	His	1493:1495	arg1	the His tag			His	the His tag					His	We then purified the protein with a Ni-chelate column that bound the His tag engineered into the C-terminus of the protein followed by an anion exchange column.
28747404	2	39	gly	glycoprotein	479:490	arg1	135-kDa glycoprotein	135-kDa glycoprotein (Gp135				PUBTATOR		135-kDa glycoprotein (Gp135	482252		Here we report that galectin (Gal)-8 regulates apical-basal polarity of Madin-Darby canine kidney (MDCK) cells via apical targeting of 135-kDa glycoprotein (Gp135).
24026960	5	64	gly	N-glycopeptide	1377:1390	arg2	N-glycopeptide			N-glycopeptide						N-glycopeptide His-Asn-Lactose	Maximum activity was observed at a concentration of 450 μg/ml (747.51 µM) for the N-glycopeptide His-Asn-Lactose with the corresponding zonal inhibition diameters (15 mm; 19 mm; 14 mm; 18 mm; 16 mm; 17 mm) against S. aureus, B. subtilis, S. caprae, E. coli, P. aeruginosa, S. sonnei.
27708373	3	2	gly	N-	652:653	arg1	sites			sites						sites	Here, we propose a novel bioinformatics method called GlycoMinestruct(http://glycomine.erc.monash.edu/Lab/GlycoMine_Struct/) for improved prediction of human N- and O-linked glycosylation sites by combining sequence and structural features in an integrated computational framework with a two-step feature-selection strategy.
26793973	13	17	gly	glycoprotein	1885:1896	arg1	a secreted glycoprotein	a secreted glycoprotein				Fterm		glycoprotein			After intravenous injection into mice, the protein had a longer plasma half-life than commercially available rhTSG-6 isolated from a mammalian cell lysate, apparently because it was recovered as a secreted glycoprotein.
26508354	1	25	gly	glycoproteins	218:230	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			Hyaluronan and phospholipids play an important role in lubrication in articular joints and provide in combination with glycoproteins exceptionally low friction coefficients.
24959308	5	24	gly	glycoproteins	760:772	arg1	tissue glycoproteins	tissue glycoproteins				Fterm		glycoproteins			In order to perform the study from both serum and tissue glycoproteins in an efficient and high-throughput manner, we indigenously developed and employed lectin microarray integrated on a microfluidic lab-on-a-chip platform.
28693200	5	97	gly	glycoproteins	542:554	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			Compared with the controls, the binding capacity of glycoproteins extracted from sorafenib-treated HCC cells to the lectins Bauhinia purpurea lectin, Dolichos biflorus agglutinin, Euonymus europaeus lectin, Helix aspersa lectin, Helix pomatia lectin, Jacalin, Maclura pomifera lectin and Vicia villosa lectin were enhanced; while, the binding capacities to the lectins Caragana arborescens lectin, Lycopersicon esculentum lectin, Limulus polyphemus lectin, Maackia amurensis lecin I, Phaseolus vulgaris leucoagglutinin, Ricinus communis agglutinin 60, Sambucus nigra lectin and Solanum tuberosum lectin were reduced (spot intensity median/background intensity median ≥2, P<0.05).
28644609	13	30	gly	GalNAc-Tyr	1644:1653	arg1	GalNAc-Tyr modified proteins			Tyr	GalNAc-Tyr modified proteins					Tyr	These results provide the first evidence that GalNAc-Tyr modified proteins and/or peptides may be ligands for hMGL and mMGL-2 and offer unique structures for the design of MGL targeting agents.
28757018	3	68	gly	glycoprotein	514:525	arg1	glycoprotein	glycoprotein				Fterm		glycoprotein			Here we show that the specific linkage of SA-containing glycan to glycoprotein or glycolipid is an attachment factor used by NA-sensitive porcine G9P[7] PRG9121 and G9P[23] PRG942, bovine G6P[1] NCDV, and canine G3P[3] strains.
26995354	5	3	gly	glycoproteins	756:768	arg1	Metabolically labeled glycoproteins	Metabolically labeled glycoproteins				Fterm		glycoproteins			Metabolically labeled glycoproteins are then tagged using Click chemistry and enriched with an isotopic recoding biotin probe.
26140596	3	43	gly	sialylated	549:558	arg1	sialylated Fc glycans				sialylated Fc glycans						Trivalent influenza virus vaccination elicited regulation of anti-hemagglutinin (HA) IgG subclass and Fc glycans, with abundance of sialylated Fc glycans (sFc) predicting quality of vaccine response.
25117250	7	4	gly	residues	1422:1429	arg1	the individual sialyl oligosaccharides			residues in	the individual sialyl oligosaccharides					residues in	They are still retained stably in whole body after 2 h while they showed significantly different in vivo dynamics in the tissue distribution, suggesting that structure/sequence of the neighboring sugar residues in the individual sialyl oligosaccharides might influence the final organ-specific distribution, which should be equivalent to the distribution of sialic acid-recognizing lectins.
27128252	7	4	gly	fucose-Phe	1258:1267	arg1	the fucose-Phe interaction			Phe	the fucose-Phe interaction					Phe	Inhibition of core fucosylation confirms the contribution of the fucose-Phe interaction to the stabilization.
27496766	3	22	gly	glycoprotein	482:493	arg1	the glycoprotein quality control system	the glycoprotein quality control system				Fterm		glycoprotein			By virtue of this, UGGT1 acts as a folding sensor in the glycoprotein quality control system in the ER.
27496766	4	23	gly	UGGT1	621:625	arg1	human UGGT2	UGGT1			human UGGT2	PUBTATOR		UGGT1	56886		On the other hand, human UGGT2 (HUGT2) has been believed to be an inactive homolog of human UGGT1 (HUGT1), whereas our recent study discovered its activity as UGGT.
28634774	1	51	gly	glycoproteins	281:293	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			Among other components of the extracellular matrix (ECM), glycoproteins and glycosaminoglycans (GAGs) have been strongly associated to the retention or misfolding of different proteins inducing the formation of deposits in amyloid diseases.
26995354	3	10	gly	glycopeptides	551:563	arg2	intact, metabolically labeled glycopeptides			intact, metabolically labeled glycopeptides						glycopeptides	In this protocol, we describe a novel mass-independent chemical glycoproteomics platform for characterizing intact, metabolically labeled glycopeptides from complex proteomes, termed Isotope Targeted Glycoproteomics (IsoTaG).
28952479	1	7	gly	glycoprotein	232:243	arg1	glycoprotein quality	glycoprotein quality				Fterm		glycoprotein			Manipulations of cell surface glycosylation or glycan decoration of selected proteins hold immense potential for exploring structure-activity relations or increasing glycoprotein quality.
28952479	1	25	gly	glycosylation	96:108	arg1	selected proteins	selected proteins				Fterm		proteins			Manipulations of cell surface glycosylation or glycan decoration of selected proteins hold immense potential for exploring structure-activity relations or increasing glycoprotein quality.
28952479	1	55	gly	proteins	143:150	arg1	glycan decoration	proteins			glycan decoration	Fterm		proteins			Manipulations of cell surface glycosylation or glycan decoration of selected proteins hold immense potential for exploring structure-activity relations or increasing glycoprotein quality.
25557319	4	51	gly	enzyme	544:549	arg1	The galactose-tolerance	enzyme			The galactose-tolerance	Fterm		enzyme			The galactose-tolerance of the enzyme was also enhanced after the immobilization, which could relieve the inhibitory effect and then tends to be beneficial for the galacto-oligosaccharides (GOS) synthesis.
24663112	6	42	gly	actinosporins	928:940	arg1	A (1)			A (1)						A (1)	As a result, two new O-glycosylated angucyclines, named actinosporins A (1) and B (2), were isolated from the broth culture of Actinokineospora sp.
26726562	5	27	gly	used	810:813	arg2	The HNTs-g-βCD composites			The HNTs-g-βCD composites						composites	The HNTs-g-βCD composites could be used as a nano adsorbent for methylene blue and a catalyst in the oxidation reaction of benzyl alcohol owing to the unique structure of β-cyclodextrin.
28614672	8	39	gly	nonfucosylated	1431:1444	arg1	nonfucosylated neutral sugars				nonfucosylated neutral sugars						The total HMO concentration and HMOs containing fucose, sialic acid, and nonfucosylated neutral sugars were significantly ( p < .05) less in retort sterilized compared with Holder pasteurized samples.
28614672	8	66	gly	containing	1395:1404	arg1	HMOs AND fucose	HMOs			fucose	OGER		HMOs	P00540		The total HMO concentration and HMOs containing fucose, sialic acid, and nonfucosylated neutral sugars were significantly ( p < .05) less in retort sterilized compared with Holder pasteurized samples.
28614672	8	66	gly	containing	1395:1404	arg1	HMOs AND sialic acid	HMOs			sialic acid	OGER		HMOs	P00540		The total HMO concentration and HMOs containing fucose, sialic acid, and nonfucosylated neutral sugars were significantly ( p < .05) less in retort sterilized compared with Holder pasteurized samples.
28614672	8	66	gly	containing	1395:1404	arg1	HMOs AND nonfucosylated neutral sugars	HMOs			nonfucosylated neutral sugars	OGER		HMOs	P00540		The total HMO concentration and HMOs containing fucose, sialic acid, and nonfucosylated neutral sugars were significantly ( p < .05) less in retort sterilized compared with Holder pasteurized samples.
26153451	0	51	gly	aglycosylated	27:39	arg1	aglycosylated IgG Fc variants	aglycosylated IgG Fc variants				Fterm		variants			Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding.
24026960	7	69	gly	N-glycopeptide	1848:1861	arg2	our potent small chain N-glycopeptide			our potent small chain N-glycopeptide						N-glycopeptide	Further in vivo testing and clinical studies will make sure to position our potent small chain N-glycopeptide in the arsenal of new broad spectrum anti-gram positive and negative agent.
27318177	6	12	gly	glycopeptides	1206:1218	arg2	144/466 unique N-linked and 10/97 unique O-linked intact glycopeptides			144/466 unique N-linked and 10/97 unique O-linked intact glycopeptides						glycopeptides	Besides, global site-specific characterization of the N- and O-linked glycan heterogeneity in the two life stages of T. cruzi was achieved by intact glycopeptide analysis, revealing 144/466 unique N-linked and 10/97 unique O-linked intact glycopeptides in epimastigotes/trypomastigotes, respectively.
27318177	6	125	gly	glycopeptide	1116:1127	arg2	intact glycopeptide analysis			intact glycopeptide analysis						glycopeptide	Besides, global site-specific characterization of the N- and O-linked glycan heterogeneity in the two life stages of T. cruzi was achieved by intact glycopeptide analysis, revealing 144/466 unique N-linked and 10/97 unique O-linked intact glycopeptides in epimastigotes/trypomastigotes, respectively.
24927271	4	62	gly	heterogeneity	714:726	arg1	individual domains			individual domains						domains	For this purpose, a rapid and informative methodology was developed to examine the heterogeneity of individual domains in mAb products.
26949374	5	14	gly	LCN2	832:835	arg1	the different N-glycan patterns	LCN2			the different N-glycan patterns	PUBTATOR		LCN2	16819		Endo- and exoglycosidases were used to investigate the different N-glycan patterns of LCN2.
25240021	5	55	gly	KIS12-7	808:814	arg1	The cell-wall peptidoglycan	KIS12-7			The cell-wall peptidoglycan	Cterm		KIS12-7			The cell-wall peptidoglycan of strain KIS12-7(T) was of the type B2 and the acyl type was acetyl.
25710501	6	52	gly	possessing	907:916	arg1	a plastidial protein AND a C-terminal carbohydrate binding module	a plastidial protein		an N-terminal coiled coil domain	a C-terminal carbohydrate binding module	Fterm	Site	protein		domain	PTST is a plastidial protein possessing an N-terminal coiled coil domain and a C-terminal carbohydrate binding module (CBM).
27318177	5	77	gly	glycoproteins	873:885	arg1	170 and 334 glycoproteins	170 and 334 glycoproteins				Fterm		glycoproteins			Among them, 170 and 334 glycoproteins were exclusively identified in epimastigotes and trypomastigotes, respectively.
25731097	4	79	gly	used	900:903	arg2	the HCPT@starch-GNS composite			the HCPT@starch-GNS composite						composite	After the loading of the commonly used anticancer drug hydroxycamptothecin (HCPT) via physisorption on starch-GNS, the HCPT@starch-GNS composite exhibited a high drug loading capacity and was therefore used for cellular imaging and drug delivery studies.
25731097	7	61	gly	used	1449:1452	arg2	the starch-GNS composite			the starch-GNS composite						composite	Therefore, the starch-GNS composite could be used as an ideal nano-carrier for drug delivery and offered a new avenue for broadening the application of graphene in biomedicine.
25425657	1	6	gly	α2,6-sialylated	194:208	arg1	α2,6-sialylated glycan epitopes			α2,6-sialylated glycan epitopes							We previously found that a lectin, Sambucus sieboldiana agglutinin (SSA), bound to α2,6-sialylated glycan epitopes on transferrin and inhibited anti-transferrin antibody binding to the antigen in ELISA (SSA inhibition).
25425657	1	49	gly	epitopes	217:224	arg1	transferrin	transferrin			epitopes	OGER		transferrin	P02787		We previously found that a lectin, Sambucus sieboldiana agglutinin (SSA), bound to α2,6-sialylated glycan epitopes on transferrin and inhibited anti-transferrin antibody binding to the antigen in ELISA (SSA inhibition).
25703680	6	41	gly	glycosylation	939:951	arg2	specific glycosylation sites			specific glycosylation sites						sites	From the model, the substrate binding cleft of the enzyme was redesigned in a manner that preferentially hydrolyzes glycans at specific glycosylation sites of triterpenoids.
26949374	0	86	gly	glycosylated	101:112	arg1	glycosylated Lipocalin 2	glycosylated Lipocalin 2				OGER		Lipocalin 2	P80188		Lipopolysaccharide-induced inflammation or unilateral ureteral obstruction yielded multiple types of glycosylated Lipocalin 2.
25582509	7	35	gly	glycopeptides	1796:1808	arg2	glycopeptides			glycopeptides						glycopeptides	Taken together, these findings illustrate the influence of charge carrier over the energy-resolved vibrational activation/dissociation characteristics of glycopeptides, and serve to suggest potential strategies that exploit the analytically useful features uniquely afforded by specific charge carriers or combinations thereof.
25425657	6	53	gly	glycosylation	940:952	arg2	SSA-binding (glycosylation) sites			SSA-binding (glycosylation) sites						sites	To examine the importance of proximity between antigen epitopes and SSA-binding (glycosylation) sites, we prepared two anti-peptide antibodies against partial amino acid sequences of transferrin.
28624360	1	62	gly	heparin+glycoprotein	344:363	arg1	heparin+glycoprotein IIb/IIIa inhibitors	heparin+glycoprotein IIb/IIIa inhibitors				Fterm		heparin+glycoprotein			BACKGROUND Studies have shown reduction in major bleeding with trans-radial intervention (TRI) compared with trans-femoral intervention (TFI), and with use of bivalirudin compared with heparin+glycoprotein IIb/IIIa inhibitors (GPI).
27318177	7	107	gly	glycoproteins	1357:1369	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			Conclusively, this study documents the significant T. cruzi stage-specific expression of glycoproteins that can help to better understand the T. cruzi phenotype and response caused by the interaction with different hosts during its complex life cycle.
28911187	6	31	gly	α-galacto-oligosaccharides	784:809	arg1	BF052 strain	strain			α-galacto-oligosaccharides	Fterm		strain			This research highlights relevant genes involving in its adaptive responses to industrial and/or environmental stresses and utilization of α-galacto-oligosaccharides in BF052 strain compared with other representative bifidobacterial genomes.
28644609	8	40	gly	GalNAc-Tyr	1205:1214	arg1	GalNAc-Tyr determinants			Tyr	GalNAc-Tyr determinants					Tyr	Both hMGL and mMGL-2 bound tightly to GalNAc-Tyr determinants.
29068272	8	32	gly	l-arabinose	1000:1010	arg1	phenylalanine			phenylalanine	phenylalanine		AminoAcid			phenylalanine	Strain FLL521T showed physiological and biochemical differences with the related strains in the Voges-Proskauer test, hydrolysis of l-arginine, utilization of d-mannose, inositol, phenylalanine and acid production from l-arabinose.
25117226	3	13	gly	MUC1	492:495	arg1	YMB-S, N-linked glycan structures	MUC1			YMB-S, N-linked glycan structures	PUBTATOR		MUC1	4582		We demonstrate lectin affinity chromatographic methods for determining O-linked glycan structures of MUC1 purified from a breast cancer cell line, YMB-S, N-linked glycan structures of serum prostate-specific antigen from prostate cancer, and serum alkaline phosphatases from choriocarcinoma.
25117226	3	13	gly	MUC1	492:495	arg1	O-linked glycan structures	MUC1			O-linked glycan structures	PUBTATOR		MUC1	4582		We demonstrate lectin affinity chromatographic methods for determining O-linked glycan structures of MUC1 purified from a breast cancer cell line, YMB-S, N-linked glycan structures of serum prostate-specific antigen from prostate cancer, and serum alkaline phosphatases from choriocarcinoma.
25117226	3	20	gly	antigen	599:605	arg1	YMB-S, N-linked glycan structures	prostate-specific antigen			YMB-S, N-linked glycan structures	PUBTATOR		prostate-specific antigen	354		We demonstrate lectin affinity chromatographic methods for determining O-linked glycan structures of MUC1 purified from a breast cancer cell line, YMB-S, N-linked glycan structures of serum prostate-specific antigen from prostate cancer, and serum alkaline phosphatases from choriocarcinoma.
25117226	3	20	gly	antigen	599:605	arg1	O-linked glycan structures	prostate-specific antigen			O-linked glycan structures	PUBTATOR		prostate-specific antigen	354		We demonstrate lectin affinity chromatographic methods for determining O-linked glycan structures of MUC1 purified from a breast cancer cell line, YMB-S, N-linked glycan structures of serum prostate-specific antigen from prostate cancer, and serum alkaline phosphatases from choriocarcinoma.
28260782	4	20	gly	composition	521:531	arg1	acetylated sugars			position,	acetylated sugars					position,	Cell wall composition, detailed xylan structure characterization and enzyme kinetics and activity assays on acetylated sugars and xylooligosaccharides demonstrate that BS1 is an esterase that cleaves acetyl moieties from the xylan backbone at O-2 and O-3 positions of xylopyranosyl residues.
28260782	4	20	gly	composition	521:531	arg1	xylooligosaccharides			position,	xylooligosaccharides					position,	Cell wall composition, detailed xylan structure characterization and enzyme kinetics and activity assays on acetylated sugars and xylooligosaccharides demonstrate that BS1 is an esterase that cleaves acetyl moieties from the xylan backbone at O-2 and O-3 positions of xylopyranosyl residues.
25032222	9	83	gly	glycosylation	1426:1438	arg1	ICAM-1 transmembrane protein	ICAM-1 transmembrane protein				Fterm		protein			Taken together, silibinin inhibits ICAM-1 expression and its function through altered O-linked glycosylation in NF-κB and STAT1 signaling pathways and decreases the N-linked glycosylation of ICAM-1 transmembrane protein in proinflammatory cytokine-stimulated ARPE-19 cells.
25817398	1	4	gly	mannoproteins	167:179	arg1	carbohydrate composition	mannoproteins			carbohydrate composition	Fterm		mannoproteins			Significant differences in carbohydrate composition of mannoproteins obtained from yeast and hyphal cell walls of Candida albicans (serotypes A and B) were found.
27188244	8	129	gly	used	1660:1663	arg2	multilayer composition			multilayer composition						position	Overall, multilayer composition can be used to direct cell-matrix interactions, and hence stem cell fates showing for the first time that PEMs made of biogenic polyelectrolytes undergo significant remodeling of terminal protein layers, which seems to enable cells to form a more adequate extracellular matrix-like environment.
26905395	6	22	gly	RS-7-4	767:772	arg1	The peptidoglycan type	RS-7-4			The peptidoglycan type	Cterm		RS-7-4			The peptidoglycan type of strain RS-7-4(T) was found to be A4α L-Lys-L-Thr-D-Asp.
25425657	2	61	gly	α2,6-sialylated	416:430	arg1	α2,6-sialylated transferrin	α2,6-sialylated transferrin				OGER		α2,6-sialylated transferrin	P02787		Here we report that SSA inhibition is applicable to immunohistochemistry, localizing α2,6-sialylated transferrin in the liver.
25582509	5	67	gly	glycopeptides	1287:1299	arg2	the various doubly sodiated glycopeptides			the various doubly sodiated glycopeptides						glycopeptides	By contrast, the various doubly sodiated glycopeptides were found to dissociate over a significantly higher but narrow range of collision energies, and exhibited only glycan cleavages.
28407595	4	10	gly	oxidase	544:550	arg1	a his-tag	cytochrome c oxidase			a his-tag	OGER		cytochrome c oxidase			As an example we employed cytochrome c oxidase from P. denitrificans with a his-tag fused to the C-terminus of subunitI.
27708373	5	1	gly	N-	1194:1195	arg1	sites			sites						sites	We applied GlycoMinestruct to screen the human structural proteome and obtained high-confidence predictions for N- and O-linked glycosylation sites.
27318177	4	15	gly	N-glycosylation	760:774	arg2	1306 N-glycosylation sites			1306 N-glycosylation sites						sites	Following deglycosylation, a total of 1306 N-glycosylation sites in NxS/T/C motifs were identified from 690 T. cruzi glycoproteins.
27318177	4	65	gly	glycoproteins	834:846	arg1	690 T. cruzi glycoproteins	690 T. cruzi glycoproteins				Fterm		glycoproteins			Following deglycosylation, a total of 1306 N-glycosylation sites in NxS/T/C motifs were identified from 690 T. cruzi glycoproteins.
25056822	8	27	gly	had	970:972	arg1	HF1 AND decreased plasma lipopolysaccharide	HF1			decreased plasma lipopolysaccharide	OGER		HF1	P08603		HF1 and HP1 offspring had decreased plasma lipopolysaccharide compared with C1.
25056822	8	27	gly	had	970:972	arg1	HP1 AND decreased plasma lipopolysaccharide	HP1			decreased plasma lipopolysaccharide	OGER		HP1	P59665		HF1 and HP1 offspring had decreased plasma lipopolysaccharide compared with C1.
27318177	3	18	gly	glycopeptide	579:590	arg2	glycopeptide			glycopeptide						glycopeptide	In this study, comprehensive glycoprofiling analysis was performed in the epimastigote and trypomastigote stages of T. cruzi using two glycopeptide enrichment strategies, lectin-based and hydrophilic interaction liquid chromatography, followed by high resolution LC-MS/MS.
24026960	1	2	gly	glycopeptides	191:203	arg2	N-linked and O-linked glycopeptides			N-linked and O-linked glycopeptides						glycopeptides	Our objective is to synthesize the smaller chain N-linked and O-linked glycopeptides using sugars belong to mono, di and polysaccharides, with the efforts mainly directed towards the identification of antibacterial compounds.
28149301	7	29	gly	linked	1061:1066	arg1	lignin AND individual hemicellulosic polysaccharides	lignin			individual hemicellulosic polysaccharides	Fterm		lignin			Feruoylation results in a wall with individual hemicellulosic polysaccharides (arabinoxylans) covalently linked to each other and to lignin.
27423948	2	45	gly	sialylated	343:352	arg1	Sia-GC				Sia-GC						Human milk sialylated glycoconjugates (Sia-GC) are bioactive compounds known to act as prebiotics and promote neurodevelopment, immune function, and gut maturation in newborns.
27268480	12	78	gly	pigs	2206:2209	arg1	Gal-free pericardium	pigs			Gal-free pericardium	OGER		pigs	Q96S52		This study measures the tissue equivalency between standard pig pericardium and Gal-free pericardium from genetically modified pigs as a first step towards making Gal-free BHVs.
24527702	3	28	gly	used	399:402	arg2	The resulting GO-carrageenan (GO-Car) composite			The resulting GO-carrageenan (GO-Car) composite						composite	The resulting GO-carrageenan (GO-Car) composite was further used as a substrate for biomimetic and cell-mediated mineralization of hydroxyapatite (HA).
28351515	10	60	gly	sialylation	1613:1623	arg1	sialylation				sialylation						In summary, we suggest that the concentration of the donor substrate of sialyltransferases, which can be regarded as a sensor for the environmental conditions of a cell, regulates not only total sialylation, but also the quality of sialylation.
25117226	1	21	gly	glycoproteins	205:217	arg1	glycan motifs	glycoproteins			glycan motifs	Fterm		glycoproteins			Serial lectin affinity chromatography is a convenient technique for characterizing glycan motifs (terminal glycan structures) of glycoproteins or released glycans.
25117226	1	21	gly	glycoproteins	205:217	arg1	terminal glycan structures	glycoproteins			terminal glycan structures	Fterm		glycoproteins			Serial lectin affinity chromatography is a convenient technique for characterizing glycan motifs (terminal glycan structures) of glycoproteins or released glycans.
28230255	2	41	gly	pectin	177:182	arg1	neutral sugar composition	pectin			neutral sugar composition	Fterm		pectin			In this research, changes in pectin characteristics, including pectin content, neutral sugar composition, molecular weight (Mw ) distribution and degree of methylesterification (DM), in six different growth stages (S1 to S6) of jujube fruit were assessed.
28230255	5	71	gly	monosaccharide	722:735	arg1	pectin	pectin			monosaccharide	Fterm		pectin			Arabinose proved to be the principal branched neutral monosaccharide in pectin during growth and was lost from WSP, CSP and SSP in S4 to S6.
24026960	2	21	gly	N-glycopeptides	437:451	arg2	N-glycopeptides			N-glycopeptides						N-glycopeptides	7 glycopeptides, viz., Arg-Asn-Mannose, Arg-Asn-Lactose, His-Asn-Mannose, His-Asn-Lactose (N-glycopeptides), Arg-Ser-Lactose, Arg-Thr-Lactose, Arg-Thr-Starch (O-glycopeptides) were prepared by dicyclohexyl carbodimide (DCC) coupling for amino acids using microwave oven (50W power; 15 min) and activated and coupled with respective sugar moieties using microwave oven at 120 W for 20-25 min.
24026960	2	21	gly	N-glycopeptides	437:451	arg2	His-Asn-Lactose			His-Asn-Lactose						His-Asn-Lactose	7 glycopeptides, viz., Arg-Asn-Mannose, Arg-Asn-Lactose, His-Asn-Mannose, His-Asn-Lactose (N-glycopeptides), Arg-Ser-Lactose, Arg-Thr-Lactose, Arg-Thr-Starch (O-glycopeptides) were prepared by dicyclohexyl carbodimide (DCC) coupling for amino acids using microwave oven (50W power; 15 min) and activated and coupled with respective sugar moieties using microwave oven at 120 W for 20-25 min.
24026960	2	37	gly	O-glycopeptides	505:519	arg2	O-glycopeptides			O-glycopeptides						O-glycopeptides	7 glycopeptides, viz., Arg-Asn-Mannose, Arg-Asn-Lactose, His-Asn-Mannose, His-Asn-Lactose (N-glycopeptides), Arg-Ser-Lactose, Arg-Thr-Lactose, Arg-Thr-Starch (O-glycopeptides) were prepared by dicyclohexyl carbodimide (DCC) coupling for amino acids using microwave oven (50W power; 15 min) and activated and coupled with respective sugar moieties using microwave oven at 120 W for 20-25 min.
24026960	2	39	gly	glycopeptides	348:360	arg2	7 glycopeptides			7 glycopeptides						glycopeptides	7 glycopeptides, viz., Arg-Asn-Mannose, Arg-Asn-Lactose, His-Asn-Mannose, His-Asn-Lactose (N-glycopeptides), Arg-Ser-Lactose, Arg-Thr-Lactose, Arg-Thr-Starch (O-glycopeptides) were prepared by dicyclohexyl carbodimide (DCC) coupling for amino acids using microwave oven (50W power; 15 min) and activated and coupled with respective sugar moieties using microwave oven at 120 W for 20-25 min.
27496766	0	18	gly	glycoprotein	73:84	arg1	human UDP-glucose:glycoprotein glucosyltransferases				human UDP-glucose:glycoprotein glucosyltransferases						Effects of domain composition on catalytic activity of human UDP-glucose:glycoprotein glucosyltransferases.
25582509	1	59	gly	glycopeptides	158:170	arg2	glycopeptides			glycopeptides						glycopeptides	Fragmentation of glycopeptides in tandem mass spectrometry (MS/MS) plays a pivotal role in site-specific protein glycosylation profiling by allowing specific oligosaccharide compositions and connectivities to be associated with specific loci on the corresponding protein.
28644609	6	28	gly	GalNAc-Tyr	914:923	arg1	GalNAc-Tyr modified proteins			Tyr	GalNAc-Tyr modified proteins					Tyr	Thus, detection of GalNAc-Tyr modified proteins is an important consideration when analyzing results from these reagents.
25582509	2	26	gly	glycopeptide	613:624	arg2	glycopeptide ions			glycopeptide ions						glycopeptide	Although MS/MS analysis of glycopeptides has been successfully performed using a number of distinct ion dissociation methods, relatively little is known regarding the fragmentation characteristics of glycopeptide ions with various charge carriers.
25582509	2	28	gly	glycopeptides	440:452	arg2	glycopeptides			glycopeptides						glycopeptides	Although MS/MS analysis of glycopeptides has been successfully performed using a number of distinct ion dissociation methods, relatively little is known regarding the fragmentation characteristics of glycopeptide ions with various charge carriers.
28952479	5	22	gly	glycoprotein	779:790	arg1	recombinant glycoprotein production	recombinant glycoprotein production				Fterm		glycoprotein			Concentrations of up to 500 µM had no substantial effects on viability and recombinant glycoprotein production of human embryonic kidney (HEK)-293T cells.
24026960	0	32	gly	glycopeptides	105:117	arg2	N-linked and O-linked smaller chain glycopeptides			N-linked and O-linked smaller chain glycopeptides						glycopeptides	Antimicrobial glycopeptides: synthesis and antibacterial activity of N-linked and O-linked smaller chain glycopeptides.
24026960	0	45	gly	glycopeptides	14:26	arg2	Antimicrobial glycopeptides			Antimicrobial glycopeptides						glycopeptides	Antimicrobial glycopeptides: synthesis and antibacterial activity of N-linked and O-linked smaller chain glycopeptides.
27826024	7	81	gly	compositional	962:974	arg1	tissue water, glycosaminoglycan, lipid, and pyridinoline contents			position	tissue water, glycosaminoglycan, lipid, and pyridinoline contents					position	Raman microspectroscopic analysis was performed as a function of tissue age based on the presence of multiple fluorescent double labels, to determine whether bone compositional properties (mineral/matrix ratio, tissue water, glycosaminoglycan, lipid, and pyridinoline contents, and mineral maturity/crystallinity) are similar between periosteal, osteonal, and endosteal surfaces, as well as to determine the effects of ovarian hormone depletion on them.
25582509	4	29	gly	glycopeptide	943:954	arg2	The doubly protonated glycopeptide ions			The doubly protonated glycopeptide ions						glycopeptide	The doubly protonated glycopeptide ions with various compositions were found to undergo fragmentation over a relatively low but wide range of collision energies compared with the doubly sodiated and hybrid charged ions, and were found to yield both glycan and peptide fragmentation depending on the applied collision energy.
27423948	1	78	gly	sialylated	271:280	arg1	human sialylated milk oligosaccharide				human sialylated milk oligosaccharide						Sialic acids (Sia) are key monosaccharide constituents of sialylated glycoproteins (Sia-GP), human sialylated milk oligosaccharide (Sia-MOS), and gangliosides.
27423948	1	78	gly	sialylated	271:280	arg1	Sia-MOS				Sia-MOS						Sialic acids (Sia) are key monosaccharide constituents of sialylated glycoproteins (Sia-GP), human sialylated milk oligosaccharide (Sia-MOS), and gangliosides.
27423948	1	28	gly	sialylated	230:239	arg1	Sia-GP	glycoproteins			Sia-GP	Fterm		glycoproteins			Sialic acids (Sia) are key monosaccharide constituents of sialylated glycoproteins (Sia-GP), human sialylated milk oligosaccharide (Sia-MOS), and gangliosides.
27423948	1	92	gly	glycoproteins	241:253	arg1	sialylated glycoproteins	glycoproteins			Sialic acids	Fterm		glycoproteins			Sialic acids (Sia) are key monosaccharide constituents of sialylated glycoproteins (Sia-GP), human sialylated milk oligosaccharide (Sia-MOS), and gangliosides.
27423948	1	92	gly	glycoproteins	241:253	arg1	sialylated glycoproteins	glycoproteins			key monosaccharide constituents	Fterm		glycoproteins			Sialic acids (Sia) are key monosaccharide constituents of sialylated glycoproteins (Sia-GP), human sialylated milk oligosaccharide (Sia-MOS), and gangliosides.
27423948	1	92	gly	glycoproteins	241:253	arg1	Sia-GP	glycoproteins			Sia-GP	Fterm		glycoproteins			Sialic acids (Sia) are key monosaccharide constituents of sialylated glycoproteins (Sia-GP), human sialylated milk oligosaccharide (Sia-MOS), and gangliosides.
28644609	3	59	gly	GalNAc-Tyr	426:435	arg1	GalNAc-Tyr glycopeptides			Tyr	GalNAc-Tyr glycopeptides					Tyr	To gain insight into this new type of modification, we synthesized a group of GalNAc-Tyr glycopeptides, constructed microarrays, and evaluated potential recognition of GalNAc-Tyr by a series of glycan-binding proteins.
26573895	1	65	gly	used	215:218	arg2	A β-cyclodextrin-modified attapulgite composite			A β-cyclodextrin-modified attapulgite composite						composite	A β-cyclodextrin-modified attapulgite composite was prepared and used as a dispersive micro-solid-phase extraction sorbent for the determination of benzoylurea insecticides in honey samples.
27496766	1	42	gly	glycoprotein	142:153	arg1	glycoprotein glucosyltransferase				glycoprotein glucosyltransferase						Uridine diphosphate (UDP)-glucose:glycoprotein glucosyltransferase (UGGT) 1 is a soluble protein residing in the endoplasmic reticulum (ER) and partially in ER-Golgi intermediate compartment.
27615441	12	62	gly	had	2514:2516	arg1	the composite AND sulfated glycosaminoglycan content			the composite	sulfated glycosaminoglycan content					composite	Biochemically, the composite had similar mature elastin content, sulfated glycosaminoglycan content, and collagen subtype III/I ratio but lower total collagen content when compared to sham (P = .011).
28757018	1	1	gly	domain	227:232	arg1	the terminal sialic acids			domain	the terminal sialic acids					domain	Group A rotaviruses (RVAs) are divided into neuraminidase (NA)-sensitive and NA-insensitive strains depending upon their binding affinity to the VP8* domain in the terminal sialic acids (SAs) of cell surface carbohydrates.
28644609	10	1	gly	GalNAc-Tyr	1407:1416	arg1	a GalNAc-Tyr epitope			Tyr	a GalNAc-Tyr epitope					Tyr	hMGL also bound the natural beta-amyloid peptide containing a GalNAc-Tyr epitope.
28644609	10	74	gly	containing	1394:1403	arg1	the natural beta-amyloid peptide AND a GalNAc-Tyr epitope			the natural beta-amyloid peptide	a GalNAc-Tyr epitope					peptide	hMGL also bound the natural beta-amyloid peptide containing a GalNAc-Tyr epitope.
28351515	3	73	gly	glycoproteins	496:508	arg1	the terminal monosaccharide	glycoproteins			the terminal monosaccharide	Fterm		glycoproteins			Sialic acid (Sia) is the terminal monosaccharide of most glycoproteins or glycolipids (= glycoconjugates) and involved in a variety of function on molecular (e.g. determination of protein stability and half-life) and cellular level (e.g. influenza infection).
26168161	6	32	gly	glycoproteins	571:583	arg1	These glycoproteins	These glycoproteins				Fterm		glycoproteins			These glycoproteins are mainly produced in the main nidamental glands.
24484315	0	83	gly	composition	78:88	arg1	a key determinant			position	a key determinant					position	Geographical ancestry is a key determinant of epidermal morphology and dermal composition.
25860971	8	73	gly	used	1138:1141	arg2	The dried residue			The dried residue						residue	The dried residue from the extraction of cassava starch can be used as feed for dairy cows to replace up to 100% of the corn ration.
28106279	2	23	gly	used	310:313	arg2	A β-cyclodextrin-reduced graphene oxide composite			A β-cyclodextrin-reduced graphene oxide composite						composite	A β-cyclodextrin-reduced graphene oxide composite was used as a reinforcing material in electrochemical determination of thiamethoxam.
26168161	10	33	gly	proteins	1050:1057	arg1	polysaccharides	proteins			polysaccharides	Fterm		proteins			This network is similar to the capsule network, and it associates these structural proteins with polysaccharides, melanin and bacteria to form a tight mesh.
24026960	4	42	gly	glycopeptide	1015:1026	arg2	the test glycopeptide			the test glycopeptide						glycopeptide, His-Asn-Lactose	One of the test glycopeptide, His-Asn-Lactose was found to be very effective against all the microbial strains tested and 3 other Test Compounds, viz., His-Asn-Mannose, Arg-Thr-Lactose and Arg-Thr-Starch are also proved to be effective against 2 gram positive and 2 gram negative strains tested.
28757018	7	85	gly	glycoprotein	1609:1620	arg1	N-linked glycoprotein	N-linked glycoprotein				Fterm		glycoprotein			Our study demonstrates that four NA-sensitive animal strains could have a strain-dependent binding preference toward α2,6-linked SAs (P[1] NCDV and P[3] CU-1 strains) or both α2,3- and α2,6-linked SAs (P[7] PRG9121 and P[23] PRG942 strains) to the glycolipid and N-linked glycoprotein.
24368301	9	3	gly	attached	1252:1259	arg1	the model antigen ovalbumin AND These CLR-binding carbohydrates	the model antigen ovalbumin			These CLR-binding carbohydrates	Fterm		ovalbumin			These CLR-binding carbohydrates were then covalently attached to the model antigen ovalbumin.
27318177	2	1	gly	glycoproteins	293:305	arg1	glycoproteins	glycoproteins				Fterm		glycoproteins			During T. cruzi developmental stages, glycoproteins play important role in the host-parasite interaction, such as cellular recognition, host cell invasion and adhesion, and immune evasion.
25032222	6	49	gly	glycoproteins	879:891	arg1	the O-GlcNAc levels	glycoproteins			the O-GlcNAc levels	Fterm		glycoproteins			Silibinin can increase the O-GlcNAc levels of glycoproteins in ARPE-19 cells.
28952479	8	75	gly	fucosylation	1235:1246	arg1	the recombinant glycoprotein	the recombinant glycoprotein				Fterm		glycoprotein			Sequential fucosylation of the recombinant glycoprotein, achieved by the application of increasing concentrations of PEGylated fucose up to 70 µM, correlated with a reduced antibody's binding activity in a Fcγ receptor IIIa (FcγRIIIa) binding assay.
28952479	8	81	gly	glycoprotein	1267:1278	arg1	the recombinant glycoprotein	glycoprotein			Sequential fucosylation	Fterm		glycoprotein			Sequential fucosylation of the recombinant glycoprotein, achieved by the application of increasing concentrations of PEGylated fucose up to 70 µM, correlated with a reduced antibody's binding activity in a Fcγ receptor IIIa (FcγRIIIa) binding assay.
26995354	6	33	gly	glycopeptides	868:880	arg2	Intact glycopeptides			Intact glycopeptides						glycopeptides	Intact glycopeptides are recovered by cleavage of the probe, analyzed with directed MS, and assigned by targeted mass-independent data analysis.
24603701	1	74	gly	leucine-rich	190:201	arg1	a small leucine-rich proteoglycan			leucine	a small leucine-rich proteoglycan					leucine	Fibromodulin (FMOD) is a small leucine-rich proteoglycan required for scarless fetal cutaneous wound repair.
29202734	1	52	gly	used	236:239	arg2	BACKGROUND Starch-binding domains			BACKGROUND Starch-binding domains						domains	BACKGROUND Starch-binding domains from carbohydrate binding module family 20 have been used as a tool for starch engineering.
29202734	1	82	gly	family	216:221	arg1	BACKGROUND Starch-binding domains			BACKGROUND Starch-binding domains	BACKGROUND Starch-binding domains		Site			domains	BACKGROUND Starch-binding domains from carbohydrate binding module family 20 have been used as a tool for starch engineering.
26751495	2	1	gly	O-glycoproteins	462:476	arg1	N-and O-glycoproteins	N-and O-glycoproteins				Fterm		O-glycoproteins			We analyzed both transferases in vivo and in vitro and could show significant differences in their activity towards N-and O-glycoproteins in vivo.
26044012	1	5	gly	glycoprotein	100:111	arg1	P-selectin	P-selectin				OGER		P-selectin	P16109		P-selectin is a multi-domain glycoprotein expressed on activated endothelial cells and activated platelets.
26044012	1	5	gly	glycoprotein	100:111	arg1	a multi-domain glycoprotein	a multi-domain glycoprotein				Fterm		glycoprotein			P-selectin is a multi-domain glycoprotein expressed on activated endothelial cells and activated platelets.
24981201	5	65	gly	mannoproteins	1023:1035	arg1	more carbohydrate epitopes	mannoproteins			more carbohydrate epitopes	Fterm		mannoproteins			More cell wall damage occurred in Δktr4 and Δkre2 than in Δktr1, including altered contents of the cell wall components mannoproteins, α-glucans and chitin, more carbohydrate epitopes changed on conidial surfaces, much lower conidial hydrophobicity, and thinner cell walls.
26949374	1	72	gly	glycoprotein	160:171	arg1	urinary glycoprotein lipocalin 2	urinary glycoprotein lipocalin 2				Fterm		glycoprotein			BACKGROUND The amount of urinary glycoprotein lipocalin 2 (LCN2) has been known to increase after kidney injury because of failed reabsorption by the proximal tubules or direct secretion from injured tissues.
28249373	7	53	gly	presence	1131:1138	arg2	composites AND polysaccharides			composites	polysaccharides					composites	FTIR spectroscopy data confirm the presence of functional groups typical for nHAp as well as polysaccharides in composites.
25425657	7	39	gly	N-glycosylation	1146:1160	arg2	N-glycosylation sites			N-glycosylation sites						sites	One antibody (Tf-596Ab) is against a peptide sequence, Cys596-Ala614, which is proximal to N-glycosylation sites (Asn-432 and Asn-630).
25425657	7	42	gly	sites	1162:1166	arg1	N-glycosylation sites			N-glycosylation sites						sites	One antibody (Tf-596Ab) is against a peptide sequence, Cys596-Ala614, which is proximal to N-glycosylation sites (Asn-432 and Asn-630).
25425657	7	39	gly	N-glycosylation	1146:1160	arg2	Asn-630			Asn-432 and Asn-630				transferrin	P02787	Asn-432 and Asn-630	One antibody (Tf-596Ab) is against a peptide sequence, Cys596-Ala614, which is proximal to N-glycosylation sites (Asn-432 and Asn-630).
25425657	7	42	gly	sites	1162:1166	arg1	Asn-432			Asn-432 and Asn-630				transferrin	P02787	Asn-432 and Asn-630	One antibody (Tf-596Ab) is against a peptide sequence, Cys596-Ala614, which is proximal to N-glycosylation sites (Asn-432 and Asn-630).
29202734	3	22	gly	family	618:623	arg1	only starch-binding domains			only starch-binding domains	only starch-binding domains		Site			domains	However, although 13 carbohydrate binding module families have been reported to contain starch-binding domains, only starch-binding domains from carbohydrate binding module family 20 have been well studied and introduced into plants successfully.
26793973	3	21	gly	glycoprotein	498:509	arg1	recombinant human TSG-6	recombinant human TSG-6				PUBTATOR		TSG-6	7130		We prepared stable clones of CHO cells that expressed recombinant human TSG-6 (rhTSG-6) as a secreted glycoprotein.
26793973	3	21	gly	glycoprotein	498:509	arg1	a secreted glycoprotein	a secreted glycoprotein				Fterm		glycoprotein			We prepared stable clones of CHO cells that expressed recombinant human TSG-6 (rhTSG-6) as a secreted glycoprotein.
29202734	9	17	gly	used	1757:1760	arg2	the starch-binding domains			the starch-binding domains						domains	CONCLUSION These results suggest that the starch-binding domains from carbohydrate binding module family 25 can be used as a novel tool for targeting proteins to starch granules during starch biosynthesis without side-effects on starch morphology, composition and properties.
29202734	9	45	gly	family	1740:1745	arg1	the starch-binding domains			the starch-binding domains	the starch-binding domains		Site			domains	CONCLUSION These results suggest that the starch-binding domains from carbohydrate binding module family 25 can be used as a novel tool for targeting proteins to starch granules during starch biosynthesis without side-effects on starch morphology, composition and properties.
28149301	1	8	gly	protein	152:158	arg1	polysaccharides	protein			polysaccharides	Fterm		protein			Cell wall matrices are complex composites mainly of polysaccharides, phenolics (monomers and polymers), and protein.
26837497	9	117	gly	glycosylated	1404:1415	arg1	glycosylated serum protein	glycosylated serum protein				Fterm		protein			Fasting blood glucose and glycosylated serum protein of group C (rats with diabetes that received drinking water with ISPS) were significantly lower than those of group B (rats with diabetes) (P<0.01) after treatment was administered for 2 and 4 weeks.
24368301	6	38	gly	glycosylated	954:965	arg1	CLR-Fc fusion proteins	CLR-Fc fusion proteins				Fterm		proteins			CLR-Fc fusion proteins display the CRD in a dimeric form, are properly glycosylated, and can be detected by a secondary antibody with a conjugated fluorophore.
25425657	0	20	gly	α2,6-sialylated	69:83	arg1	α2,6-sialylated transferrin	α2,6-sialylated transferrin				OGER		α2,6-sialylated transferrin	P02787		In situ visualization of a glycoform of transferrin: localization of α2,6-sialylated transferrin in the liver.
25425657	0	54	gly	glycoform	27:35	arg1	transferrin	transferrin				OGER		transferrin	P02787		In situ visualization of a glycoform of transferrin: localization of α2,6-sialylated transferrin in the liver.
24959743	4	63	gly	containing	754:763	arg1	the composition AND 10 mM glucose			the composition	10 mM glucose					position	Studies were conducted by manipulating the composition of the artificial cerebrospinal fluid (aCSF), containing either 10 mM glucose, or 20 mM lactate, or no external carbohydrate supply (aglycemia).
26079194	3	13	gly	ECM	358:360	arg1	heparan sulfate proteoglycans	ECM			heparan sulfate proteoglycans	OGER		ECM	Q13201		Fractones are composed of ubiquitous ECM components including heparan sulfate proteoglycans such as perlecan and agrin.
28693200	6	13	gly	glycoprotein	1189:1200	arg1	glycoprotein binding capacity	glycoprotein binding capacity				Fterm		glycoprotein			This difference in glycoprotein binding capacity indicates that cells treated with sorafenib could increase α-1,3GalNAc/Gal, β-1,3 Gal, GalNAcα-Ser/Thr(Tn) and α-GalNAc structures and decrease GlcNAc, sialic acid, tetra-antennary complex-type N-glycan and β-1,4Gal structures.
28407595	2	24	gly	his	370:372	arg1	histidine(his)-tag			his	histidine(his)-tag					his	PLBs are based on nickel nitrile tri-acetic acid (Ni-NTA)-functionalized agarose beads, onto which membrane proteins (MP) are bound via histidine(his)-tag.
28407595	2	30	gly	histidine	360:368	arg1	histidine(his)-tag			histidine	histidine(his)-tag					histidine	PLBs are based on nickel nitrile tri-acetic acid (Ni-NTA)-functionalized agarose beads, onto which membrane proteins (MP) are bound via histidine(his)-tag.
24248522	9	22	gly	zinc-α-2-glycoprotein	1298:1318	arg1	zinc-α-2-glycoprotein	zinc-α-2-glycoprotein				Fterm		zinc-α-2-glycoprotein			Higher abundance of bands containing secretory component, zinc-α-2-glycoprotein and carbonic anhydrase 6 was associated to a lower bitterness acceptance, while higher abundance of bands containing lactoperoxidase, prolactin-inducible protein and S-type cystatins was associated to a higher bitterness acceptance.
24326036	1	38	gly	used	237:240	arg2	A novel graphite oxide/poly(acrylic acid) grafted chitosan nanocomposite			A novel graphite oxide/poly(acrylic acid) grafted chitosan nanocomposite						nanocomposite	A novel graphite oxide/poly(acrylic acid) grafted chitosan nanocomposite (GO/CSA) was prepared and used as biosorbent for the removal of pharmaceutical compound (dorzolamide) from biomedical synthetic wastewaters.
28249783	14	13	gly	pro-inflammatory	2209:2224	arg1	lipopolysaccharide			pro	lipopolysaccharide					pro	HF/HSD and LF/HSD-fed rats also exhibited an increase in cecum and serum levels of lipopolysaccharide (LPS), a pro-inflammatory bacterial product.
25117250	1	8	gly	glycosylated	171:182	arg1	a tag				a tag						Utilizing glycosylated derivatives as a tag, we are able to explore novel counter-receptor of endogenous lectins or lectin-like molecules in vivo.
24026960	6	88	gly	N-glycopeptide	1628:1641	arg2	our N-glycopeptide			N-glycopeptide, His-Asn-Lactose						N-glycopeptide, His-Asn-Lactose	This is the first evidence based report that our N-glycopeptide, His-Asn-Lactose tested, has shown antibacterial action against both gram positive and gram negative strains.
